title: [Is the measurement of carcinoembryonic antigen still indicated in digestive cancers?].
abstract: Carcinoembryonic antigen (CEA) is not useful for detecting asymptomatic cancer. Its sensitivity and specificity are not high. For some cancers, antigen levels at the time of diagnosis provide more precise prognosis than staging alone. Regular determination of CEA is useful as a method of surveillance after surgery for cancer in the colon and in the rectum. Unfortunately the clinical gain of detecting postoperative relapses is low since curative surgical treatment is usually impossible.
authors.forename: J B
authors.initials: JB
authors.lastname: Ollyo
authors.forename: J J
authors.initials: JJ
authors.lastname: Gonvers
authors.forename: P
authors.initials: P
authors.lastname: Bauerfeind
authors.forename: A
authors.initials: A
authors.lastname: Restellini
authors.forename: T
authors.initials: T
authors.lastname: Cilluffo
authors.forename: A L
authors.initials: AL
authors.lastname: Blum
mesh_terms: D002272:Carcinoembryonic Antigen / Q000032:analysis*; D015179:Colorectal Neoplasms / Q000601:surgery; D004067:Digestive System Neoplasms / Q000276:immunology*; D006801:Humans; D011184:Postoperative Period; D011379:Prognosis; D012680:Sensitivity and Specificity
chemical_list: D002272:Carcinoembryonic Antigen
vernacular_title: Le dosage de l'antigène carcino-embryonnaire est-il encore indiqué dans les cancers digestifs?